Lot-to-lot Consistency Trial of Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccine
NCT01567865
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
818
Enrollment
OTHER
Sponsor class
Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL:
Vaccine produced in existing facility
BIOLOGICAL:
Vaccine produced in new facility
Sponsor
PATH